<DOC>
	<DOCNO>NCT01059812</DOCNO>
	<brief_summary>This trial conduct Asia . The aim clinical trial compare NN5401 ( insulin degludec/insulin aspart ( IDegAsp ) ) biphasic insulin aspart ( BIAsp ) 30 patient type 2 diabetes optimally control twice daily insulin without metformin .</brief_summary>
	<brief_title>A Pan Asian Trial Comparing Efficacy Safety NN5401 Biphasic Insulin Aspart 30 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Male female least 18 year age ( least 20 year Japan ) Type 2 diabetes mellitus ( diagnose clinically ) least 6 month Subject basal human analogue insulin , daily ( OD ) twice daily ( BID ) without metformin least 3 month subject premixed human analogue insulin selfmixed insulin regimen , contain 2040 % fast/rapidacting component , OD BID , without metformin , least 3 month HbA1c 7.010.0 % ( inclusive ) central laboratory analysis Body mass index ( BMI ) maximum 35.0 kg/m^2 Treatment oral antidiabetic drug ( OADs ) ( except metformin ) within last 8 week prior Visit 1 Treatment thiazolidinediones ( TZDs ) glucagon like peptide 1 ( GLP1 ) receptor agonist within 3 month prior Visit 1 Cardiovascular disease , within last 6 month prior Visit 1 , define : stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty Uncontrolled treated/untreated severe hypertension ( systolic blood pressure least 180 millimetre ( mm ) mercury ( Hg ) and/or diastolic blood pressure least 100 mmHg ) Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement Cancer medical history cancer ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>